Banks - Regional
Compare Stocks
5 / 10Stock Comparison
CARE vs NFBK vs NBTB vs CSGP vs ICE
Revenue, margins, valuation, and 5-year total return — side by side.
Banks - Regional
Banks - Regional
Real Estate - Services
Financial - Data & Stock Exchanges
CARE vs NFBK vs NBTB vs CSGP vs ICE — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Banks - Regional | Banks - Regional | Banks - Regional | Real Estate - Services | Financial - Data & Stock Exchanges |
| Market Cap | $580M | $588M | $2.35B | $14.83B | $88.45B |
| Revenue (TTM) | $255M | $251M | $867M | $3.41B | $12.64B |
| Net Income (TTM) | $31M | $39M | $169M | $25M | $3.30B |
| Gross Margin | 61.7% | 49.1% | 72.1% | 77.4% | 61.9% |
| Operating Margin | 15.7% | 16.1% | 25.3% | -0.8% | 38.7% |
| Forward P/E | 4.8x | 10.4x | 10.8x | 25.8x | 19.5x |
| Total Debt | $179M | $760M | $327M | $1.14B | $20.28B |
| Cash & Equiv. | $105M | $168M | $185M | $1.73B | $837M |
CARE vs NFBK vs NBTB vs CSGP vs ICE — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Carter Bankshares, … (CARE) | 100 | 371.0 | +271.0% |
| Northfield Bancorp,… (NFBK) | 100 | 128.7 | +28.7% |
| NBT Bancorp Inc. (NBTB) | 100 | 143.9 | +43.9% |
| CoStar Group, Inc. (CSGP) | 100 | 53.3 | -46.7% |
| Intercontinental Ex… (ICE) | 100 | 160.6 | +60.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CARE vs NFBK vs NBTB vs CSGP vs ICE
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CARE is the #2 pick in this set and the best alternative if momentum is your priority.
- +69.0% vs CSGP's -53.6%
NFBK ranks third and is worth considering specifically for dividends.
- 3.7% yield, 10-year raise streak, vs ICE's 1.2%, (2 stocks pay no dividend)
NBTB is the clearest fit if your priority is valuation efficiency and bank quality.
- PEG 1.53 vs ICE's 2.19
- NIM 3.1% vs NFBK's 2.0%
- Lower P/E (10.8x vs 19.5x), PEG 1.53 vs 2.19
CSGP is the clearest fit if your priority is growth exposure and sleep-well-at-night.
- Rev growth 18.7%, EPS growth -95.1%, 3Y rev CAGR 14.2%
- Lower volatility, beta 0.80, Low D/E 13.7%, current ratio 2.84x
- 18.7% FFO/revenue growth vs CARE's 6.2%
ICE carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 14 yrs, beta 0.33, yield 1.2%
- 225.3% 10Y total return vs CARE's 112.9%
- Beta 0.33, yield 1.2%, current ratio 1.02x
- 26.1% margin vs CSGP's 0.7%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 18.7% FFO/revenue growth vs CARE's 6.2% | |
| Value | Lower P/E (10.8x vs 19.5x), PEG 1.53 vs 2.19 | |
| Quality / Margins | 26.1% margin vs CSGP's 0.7% | |
| Stability / Safety | Beta 0.33 vs NFBK's 1.00, lower leverage | |
| Dividends | 3.7% yield, 10-year raise streak, vs ICE's 1.2%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +69.0% vs CSGP's -53.6% | |
| Efficiency (ROA) | 2.3% ROA vs CSGP's 0.2%, ROIC 7.5% vs -0.9% |
CARE vs NFBK vs NBTB vs CSGP vs ICE — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
CARE vs NFBK vs NBTB vs CSGP vs ICE — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
ICE leads in 2 of 6 categories
NBTB leads 1 • CARE leads 1 • NFBK leads 0 • CSGP leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
ICE leads this category, winning 3 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
ICE is the larger business by revenue, generating $12.6B annually — 50.3x NFBK's $251M. ICE is the more profitable business, keeping 26.1% of every revenue dollar as net income compared to CSGP's 0.7%.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $255M | $251M | $867M | $3.4B | $12.6B |
| EBITDAEarnings before interest/tax | $46M | $61M | $241M | $278M | $6.5B |
| Net IncomeAfter-tax profit | $31M | $39M | $169M | $25M | $3.3B |
| Free Cash FlowCash after capex | $30M | $42M | $225M | $241M | $4.3B |
| Gross MarginGross profit ÷ Revenue | +61.7% | +49.1% | +72.1% | +77.4% | +61.9% |
| Operating MarginEBIT ÷ Revenue | +15.7% | +16.1% | +25.3% | -0.8% | +38.7% |
| Net MarginNet income ÷ Revenue | +12.3% | +11.9% | +19.5% | +0.7% | +26.1% |
| FCF MarginFCF ÷ Revenue | +12.5% | +11.9% | +25.2% | +7.1% | +33.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | +22.5% | — |
| EPS Growth (YoY)Latest quarter vs prior year | +8.3% | +68.8% | +39.5% | +127.7% | +23.1% |
Valuation Metrics
NBTB leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 13.5x trailing earnings, NBTB trades at a 99% valuation discount to CSGP's 2107.2x P/E. Adjusting for growth (PEG ratio), NBTB offers better value at 1.92x vs ICE's 3.05x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $580M | $588M | $2.4B | $14.8B | $88.4B |
| Enterprise ValueMkt cap + debt − cash | $654M | $1.2B | $2.5B | $14.2B | $107.9B |
| Trailing P/EPrice ÷ TTM EPS | 18.71x | 19.54x | 13.53x | 2107.23x | 27.06x |
| Forward P/EPrice ÷ next-FY EPS est. | 4.77x | 10.42x | 10.80x | 25.84x | 19.48x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 1.92x | — | 3.05x |
| EV / EBITDAEnterprise value multiple | 16.34x | 24.19x | 10.35x | 83.74x | 16.71x |
| Price / SalesMarket cap ÷ Revenue | 2.28x | 2.34x | 2.71x | 4.57x | 7.00x |
| Price / BookPrice ÷ Book value/share | 1.40x | 0.83x | 1.21x | 1.77x | 3.08x |
| Price / FCFMarket cap ÷ FCF | 18.25x | 19.64x | 10.75x | 361.59x | 20.62x |
Profitability & Efficiency
ICE leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
ICE delivers a 11.6% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $0 for CSGP. CSGP carries lower financial leverage with a 0.14x debt-to-equity ratio, signaling a more conservative balance sheet compared to NFBK's 1.08x. On the Piotroski fundamental quality scale (0–9), ICE scores 9/9 vs CSGP's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +7.6% | +5.5% | +9.5% | +0.3% | +11.6% |
| ROA (TTM)Return on assets | +0.7% | +0.7% | +1.1% | +0.2% | +2.3% |
| ROICReturn on invested capital | +5.7% | +2.0% | +7.9% | -0.9% | +7.5% |
| ROCEReturn on capital employed | +1.5% | +2.5% | +2.4% | -0.8% | +9.5% |
| Piotroski ScoreFundamental quality 0–9 | 8 | 7 | 7 | 5 | 9 |
| Debt / EquityFinancial leverage | 0.43x | 1.08x | 0.17x | 0.14x | 0.70x |
| Net DebtTotal debt minus cash | $73M | $592M | $142M | -$589M | $19.4B |
| Cash & Equiv.Liquid assets | $105M | $168M | $185M | $1.7B | $837M |
| Total DebtShort + long-term debt | $179M | $760M | $327M | $1.1B | $20.3B |
| Interest CoverageEBIT ÷ Interest expense | 0.39x | 0.46x | 1.05x | 1.58x | 6.53x |
Total Returns (Dividends Reinvested)
CARE leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CARE five years ago would be worth $18,721 today (with dividends reinvested), compared to $4,112 for CSGP. Over the past 12 months, CARE leads with a +69.0% total return vs CSGP's -53.6%. The 3-year compound annual growth rate (CAGR) favors CARE at 24.9% vs CSGP's -22.2% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +34.8% | +26.5% | +9.3% | -46.7% | -2.1% |
| 1-Year ReturnPast 12 months | +69.0% | +31.5% | +9.0% | -53.6% | -10.4% |
| 3-Year ReturnCumulative with dividends | +94.7% | +65.7% | +54.1% | -52.9% | +50.8% |
| 5-Year ReturnCumulative with dividends | +87.2% | +0.2% | +29.9% | -58.9% | +43.4% |
| 10-Year ReturnCumulative with dividends | +112.9% | +20.6% | +102.2% | +77.5% | +225.3% |
| CAGR (3Y)Annualised 3-year return | +24.9% | +18.3% | +15.5% | -22.2% | +14.7% |
Risk & Volatility
Evenly matched — NFBK and ICE each lead in 1 of 2 comparable metrics.
Risk & Volatility
ICE is the less volatile stock with a 0.33 beta — it tends to amplify market swings less than NFBK's 1.00 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NFBK currently trades 99.0% from its 52-week high vs CSGP's 35.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.56x | 1.00x | 0.89x | 0.80x | 0.33x |
| 52-Week HighHighest price in past year | $26.58 | $14.21 | $46.92 | $97.43 | $189.35 |
| 52-Week LowLowest price in past year | $15.37 | $9.90 | $39.20 | $33.31 | $143.17 |
| % of 52W HighCurrent price vs 52-week peak | +98.5% | +99.0% | +96.1% | +35.9% | +82.5% |
| RSI (14)Momentum oscillator 0–100 | 75.4 | 57.0 | 57.3 | 30.4 | 38.8 |
| Avg Volume (50D)Average daily shares traded | 276K | 258K | 236K | 5.9M | 3.0M |
Analyst Outlook
Evenly matched — NFBK and ICE each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: CARE as "Buy", NFBK as "Hold", NBTB as "Hold", CSGP as "Buy", ICE as "Buy". Consensus price targets imply 77.0% upside for CSGP (target: $62) vs 2.1% for NBTB (target: $46). For income investors, NFBK offers the higher dividend yield at 3.73% vs ICE's 1.24%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Hold | Buy | Buy |
| Price TargetConsensus 12-month target | $27.00 | $14.50 | $46.00 | $61.91 | $195.71 |
| # AnalystsCovering analysts | 4 | 9 | 10 | 25 | 36 |
| Dividend YieldAnnual dividend ÷ price | — | +3.7% | +3.2% | — | +1.2% |
| Dividend StreakConsecutive years of raises | 0 | 10 | 12 | — | 14 |
| Dividend / ShareAnnual DPS | — | $0.52 | $1.43 | — | $1.93 |
| Buyback YieldShare repurchases ÷ mkt cap | +3.4% | +3.2% | +0.4% | +3.9% | +1.6% |
ICE leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). NBTB leads in 1 (Valuation Metrics). 2 tied.
CARE vs NFBK vs NBTB vs CSGP vs ICE: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CARE or NFBK or NBTB or CSGP or ICE a better buy right now?
For growth investors, CoStar Group, Inc.
(CSGP) is the stronger pick with 18. 7% revenue growth year-over-year, versus 6. 2% for Carter Bankshares, Inc. (CARE). NBT Bancorp Inc. (NBTB) offers the better valuation at 13. 5x trailing P/E (10. 8x forward), making it the more compelling value choice. Analysts rate Carter Bankshares, Inc. (CARE) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CARE or NFBK or NBTB or CSGP or ICE?
On trailing P/E, NBT Bancorp Inc.
(NBTB) is the cheapest at 13. 5x versus CoStar Group, Inc. at 2107. 2x. On forward P/E, Carter Bankshares, Inc. is actually cheaper at 4. 8x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: NBT Bancorp Inc. wins at 1. 53x versus Intercontinental Exchange, Inc. 's 2. 19x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — CARE or NFBK or NBTB or CSGP or ICE?
Over the past 5 years, Carter Bankshares, Inc.
(CARE) delivered a total return of +87. 2%, compared to -58. 9% for CoStar Group, Inc. (CSGP). Over 10 years, the gap is even starker: ICE returned +225. 3% versus NFBK's +20. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CARE or NFBK or NBTB or CSGP or ICE?
By beta (market sensitivity over 5 years), Intercontinental Exchange, Inc.
(ICE) is the lower-risk stock at 0. 33β versus Northfield Bancorp, Inc. 's 1. 00β — meaning NFBK is approximately 204% more volatile than ICE relative to the S&P 500. On balance sheet safety, CoStar Group, Inc. (CSGP) carries a lower debt/equity ratio of 14% versus 108% for Northfield Bancorp, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — CARE or NFBK or NBTB or CSGP or ICE?
By revenue growth (latest reported year), CoStar Group, Inc.
(CSGP) is pulling ahead at 18. 7% versus 6. 2% for Carter Bankshares, Inc. (CARE). On earnings-per-share growth, the picture is similar: Carter Bankshares, Inc. grew EPS 32. 1% year-over-year, compared to -95. 1% for CoStar Group, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CARE or NFBK or NBTB or CSGP or ICE?
Intercontinental Exchange, Inc.
(ICE) is the more profitable company, earning 26. 1% net margin versus 0. 2% for CoStar Group, Inc. — meaning it keeps 26. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ICE leads at 38. 7% versus -2. 2% for CSGP. At the gross margin level — before operating expenses — CSGP leads at 75. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CARE or NFBK or NBTB or CSGP or ICE more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, NBT Bancorp Inc. (NBTB) is the more undervalued stock at a PEG of 1. 53x versus Intercontinental Exchange, Inc. 's 2. 19x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, Carter Bankshares, Inc. (CARE) trades at 4. 8x forward P/E versus 25. 8x for CoStar Group, Inc. — 21. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CSGP: 77. 0% to $61. 91.
08Which pays a better dividend — CARE or NFBK or NBTB or CSGP or ICE?
In this comparison, NFBK (3.
7% yield), NBTB (3. 2% yield), ICE (1. 2% yield) pay a dividend. CARE, CSGP do not pay a meaningful dividend and should not be held primarily for income.
09Is CARE or NFBK or NBTB or CSGP or ICE better for a retirement portfolio?
For long-horizon retirement investors, Intercontinental Exchange, Inc.
(ICE) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 33), 1. 2% yield, +225. 3% 10Y return). Both have compounded well over 10 years (ICE: +225. 3%, CSGP: +77. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CARE and NFBK and NBTB and CSGP and ICE?
These companies operate in different sectors (CARE (Financial Services) and NFBK (Financial Services) and NBTB (Financial Services) and CSGP (Real Estate) and ICE (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: CARE is a small-cap quality compounder stock; NFBK is a small-cap income-oriented stock; NBTB is a small-cap deep-value stock; CSGP is a mid-cap high-growth stock; ICE is a mid-cap quality compounder stock. NFBK, NBTB, ICE pay a dividend while CARE, CSGP do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.